Exabis Library
Welcome to the e-CCO Library!
P0066: Enhanced transcription of human endogenous retroviruses and downregulation of TRIM28 in patients with Crohn’s disease and ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0067: Exploring potential therapeutic implication of anti inflammatory drugs and Probiotic in Experimental Models of IBD-dependent Sarcopenia
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0068: Distribution of α4β7 integrin and MAdCAM-1 expression according to the location of intestinal inflammation in a murine model of spontaneous chronic enterocolitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0069: TP-317x7x7x7 a Novel BLT1 Agonist Oral Therapy for Inflammatory Bowel Diseasex7x7x7 Exhibits Anti-Inflammatory and Epithelial Barrier Protective Efficacy in Murine DSS Colitis and TNFΔARE Ileitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P006: Anatomical brain changes in active Crohn’s disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P006: Correlation of small intestinal permeability, faecal calprotectin and barrier genes in multiple-affected families with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P006: Engineered propionate-producing bacteria attenuates murine colitis by modulating the immune function of resident macrophages via histone deacetylase
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P006: Host-genetics, dysbiosis, and clinical history explains fecal metabolic alterations in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P006: Loss of protein tyrosine phosphatase non-receptor type 23 (PTPN23) in intestinal epithelial cells induces inflammation and epithelial hyperproliferation
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P006: MiR-192 is associated with stricturing phenotype in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P006: Transcriptomic profiling of intestinal macrophages isolated from patients reveals a profound gene expression reprogramming underlying IBD pathogenesis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P007 GC1qR driven oxidative phosphorylation is essential for intestinal goblet cell differentiation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0070: Distinct Serum Proteome Alterations Following Vedolizumab and Ustekinumab Therapy in IBD Patients
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0071: Host fecal proteolytic activity is increased following antibiotic treatment in healthy individualsx7x7x7 but not patients with pouchitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0072: Unveiling mesenteric and intestinal changes in Crohn’s disease: insights into fibrosis from surgical specimens
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0073: Evaluation of PYGL as a Biomarker and Therapeutic Target in Ulcerative Colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0074: Colonic goblet cell dysfunction and gastric intestinal metaplasia in patients with anterior gradient 2 defects and infantile Inflammatory bowel disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0075: Evaluation of the modulatory potential of polyphenolic compounds on intestinal inflammation at the transcriptomic level
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0076: A novel CXCR7 agonist inhibits the intestinal inflammation in Dextran sulfate sodium(DSS)-induced colitis animal model.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0077: Identification of symbiote candidates for pouchitis in patients with ulcerative colitis.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM